Immunotherapy is safe and feasible in cancer patients treated for HIV, study suggests
Immunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of tumour types
ESMO Media Releases
Pregnancy may be possible after chemotherapy for breast cancer patients – but many no longer wish to
Chemotherapy is known to have a negative impact on the reproductive potential of young breast cancer patients. Its effects on women’s post-treatment fertility, however, are still poorly understood.
New research shows benefits of exercise for first time in advanced lung cancer
Most people with lung cancer are unaware of the benefits of regular exercise, yet new data show it can significantly reduce fatigue and improve well being.
Regular exercise should be part of cancer care for all patients
Including exercise or sport as part of cancer care can significantly improve symptom management, quality of life and fitness during and after treatment, French researchers have concluded in two presentations to be reported at the ESMO 2018 Congress in Munich.
Social vulnerability and medical skepticism top factors limiting adherence to cancer screening: an online survey
Results from the EDIFICE 6 survey identified major social and behavioural indicators for reluctance to undergo cancer screening tests in the French population
Study indicates HER2+ early breast cancers where shorter-course trastuzumab could be an option
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity
Securing access to optimal cancer care through innovation, integration and sustainability
Securing access to optimal cancer care for all patients can only be achieved through integrated, sustainable translation of today’s scientific advances into tomorrow’s treatments
Huge variations between countries in time for reimbursement decisions on new cancer drugs
Some European countries take more than twice as long as others to reach HTA decisions to reimburse new cancer drugs following their approval by the EMA
Women more prone to selected oesophagogastric cancer chemotherapy side-effects
Men and women may need to be treated differently – at least when it comes to some types of cancer.
One in six premenopausal early breast cancer patients do not adhere to hormonal therapy
Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy after one year of treatment
ESMO Women for Oncology Forum focuses on power sharing to foster gender equality
The Women for Oncology (W4O) Forum at ESMO 2018, Sharing The Power, on Friday, 19 October*, will focus on power sharing between women and men working in oncology as a way of fostering gender equality.
ESMO advocacy for patient-centred care takes on global dimension
Supportive and palliative care should be an integral part of cancer treatment, the European Society for Medical Oncology claimed in its position paper.